BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kwon EK, Seefeldt M, Drolet BA. Infantile hemangiomas: an update. Am J Clin Dermatol 2013;14:111-23. [PMID: 23338947 DOI: 10.1007/s40257-013-0008-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Auger N, Fraser W, Arbour L, Healy‐profitós J, Drolet B. Pre‐eclampsia and risk of infantile haemangioma. Br J Dermatol 2017;176:371-7. [DOI: 10.1111/bjd.14958] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Lee JC, Modiri O, England RW, Shawber CJ, Wu JK. Propranolol Therapy in Infantile Hemangioma: It Is Not Just About the Beta. Plast Reconstr Surg 2021;147:875-85. [PMID: 33776033 DOI: 10.1097/PRS.0000000000007699] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Warner C, Dinulos JG. Core concepts in congenital melanocytic nevi and infantile hemangiomas. Current Opinion in Pediatrics 2014;26:130-5. [DOI: 10.1097/mop.0000000000000052] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
4 Chen S, Zhuang K, Sun K, Yang Q, Ran X, Xu X, Mu C, Zheng B, Lu Y, Zeng J, Dai Y, Pradhan S, Ran Y. Itraconazole Induces Regression of Infantile Hemangioma via Downregulation of the Platelet-Derived Growth Factor-D/PI3K/Akt/mTOR Pathway.J Invest Dermatol. 2019;139:1574-1582. [PMID: 30690033 DOI: 10.1016/j.jid.2018.12.028] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
5 Strumila A, Kazlauskas V, Pošiūnas G, Verkauskas G, Beiša V. Infantile hemangioma: Predicting proliferation by infrared thermography. Medicina 2017;53:85-9. [DOI: 10.1016/j.medici.2017.04.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
6 Woody MM, Levy ML, Weinfeld AB. Propranolol for Preoperative Management of a Large Infantile Hemangioma. Pediatr Dermatol 2016;33:e198-200. [DOI: 10.1111/pde.12850] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Ding Y, Zhang J, Yu S, Xiang F, Kang X. Risk factors for infantile hemangioma: a meta-analysis. World J Pediatr 2020;16:377-84. [DOI: 10.1007/s12519-019-00327-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
8 Soukoulis IW, Liang MG, Fox VL, Mulliken JB, Alomari AI, Fishman SJ. Gastrointestinal Infantile Hemangioma: Presentation and Management. J Pediatr Gastroenterol Nutr 2015;61:415-20. [PMID: 25859824 DOI: 10.1097/MPG.0000000000000812] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 3.2] [Reference Citation Analysis]
9 Munabi NC, England RW, Edwards AK, Kitajewski AA, Tan QK, Weinstein A, Kung JE, Wilcox M, Kitajewski JK, Shawber CJ, Wu JK. Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation. Stem Cells Transl Med 2016;5:45-55. [PMID: 26574555 DOI: 10.5966/sctm.2015-0076] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
10 Leung AK, Lam JM, Leong KF, Hon KL. Infantile Hemangioma: An Updated Review. CPR 2021;17:55-69. [DOI: 10.2174/1573396316666200508100038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Peterman CM, Gibson RS, Lillis AP, Fishman SJ, Liang MG. Clinical and radiological characteristics of patients with retroperitoneal infantile hemangiomas. Pediatr Dermatol 2019;36:823-9. [PMID: 31600835 DOI: 10.1111/pde.13982] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Neville BW, Damm DD, Allen CM, Chi AC. Soft Tissue Tumors. Color Atlas of Oral and Maxillofacial Diseases. Elsevier; 2019. pp. 299-347. [DOI: 10.1016/b978-0-323-55225-7.00012-9] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]